Moxaverine

Moxaverine

Salts []
Moxaverine hydrochloride

Molecular structure via molpic based on CDK

Physical properties []
Molecular mass	307.4 g/mol ^[1]
Predicted LogP	4.8 ^[1]

Structural Identifiers []
Molecular formula	C₂₀H₂₁NO₂ ^[1]
IUPAC name	1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline ^[1]
SMILES	CCC1=NC(=C2C=C(C(=CC2=C1)OC)OC)CC3=CC=CC=C3 ^[1]
InChI	InChI=1S/C20H21NO2/c1-4-16-11-15-12-19(22-2)20(23-3)13-17(15)18(21-16)10-14-8-6-5-7-9-14/h5-9,11-13H,4,10H2,1-3H3 ^[1]
InChIKey	MYCMTMIGRXJNSO-UHFFFAOYSA-N ^[1]

Moxaverine (also known as Moxaverine, 1-Benzyl-3-ethyl-6,7-dimethoxyisoquinoline, 10539-19-2, Moxaverina, Moxaverinum, P3P08Y1XJ4, Dtxsid6057613, Dtxcid7031402, A03AD30 or 234-117-5) is a opioid substance of the diarylethylamine class.

Chemistry

Salts []

Moxaverine is typically found in the form of its hydrochloride salt.

Stereochemistry []

Moxaverine is a achiral mixture.

Pharmacology

ATC Classification

In the alimentary tract and metabolism (A) moxaverine acts

Metabolism

Subjective effects []

Physical effects
Constipation Cough suppression Difficulty urinating Itchiness Nausea Pain relief Pupil constriction Respiratory depression Sedation Stomach cramp

Cognitive effects
Anxiety suppression Cognitive euphoria Compulsive redosing Increased music appreciation Thought deceleration

Visual effects
Double vision

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 70882, Moxaverine. Accessed February 17, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/70882
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Moxaverine. UNII: P3P08Y1XJ4. Global Substance Registration System. Accessed February 17, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/P3P08Y1XJ4

AnodyneWiki